Ionis Rare Disease Webinar Series: Hereditary Angioedema

(48:3)

Ionis Rare Disease Webinar Series - Acromegaly #PituitaryDiseases

(52:22)

Rare Disease Panel

(40:34)

2019 FAST Summit on Angelman Syndrome - ASO Therapy for AS - Dr. Frank Bennett, Ionis Pharmaceutical

(24:51)

Ionis RareDiseaseDay ChristinaDawn

(10:35)

Webinar: Demystifying the ATTUNE study - Part1

(32:8)

Sneak Peek of the 2023 Nano-rare Patient Colloquium

(36:7)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

ROLLING LUMINOSITY RAREST AURA IN SOLS RNG (1.2 BILLION) | SOLS RNG

(44)

2024 ASF Family Conference - Pharma and Biotech Industry Update

(48:5)

RNA Targeting Technology – Chemistry and Delivery | Richard Geary

(1:10:26)

n-Lorem’s Clinical Experience Paves the Way for Precision Medicine Using Antisense Oligonucleotides

(28:40)

Ionic Rare Earths (IXR) - USA \u0026 Europe Competing for Critical Minerals

(23:1econd)

N.Whiffin - The non-coding exome in rare disease: from diagnosis to therapies

(47:35)

Science Sundays - Adrian Krainer: Shooting the messenger: 'Antisense' therapies for rare diseases

(1:5:43)

Ionis Update on Tegsedi plus short Q\u0026A on TTR silencer treatments

(32:50)

The Recent Years: 2011-2019 | Ionis Pharmaceuticals

(15:35)

Ionis Pharmaceuticals Announces Phase 3 Results In Familial Chylomicronemia Syndrome For Olezarsen

(1:48)

The n-Lorem Foundation Provides Treatment for Patients with Ultra-Rare Diseases

(3:16)

Where to Find Ionis – WoW Rare NPC Location Guide

(32)

💊 Ionis Pharmaceuticals: A Journey into the Future 🚀 of Investment of IONS Stock 📈 💰 #investing

(4:36)

Ionis Pharmaceuticals CEO: High-Profile Partners | Mad Money | CNBC

(8:7)

2023 Ionis Pharmaceuticals Update

(20:57)

ALS Clinical Trials Unboxed: IONIS (ION363)

(30:32)

Laurence Mignon - Ionis Research Update

(12:4)

When Two Competitive CEO-scientists have Competing Drugs

(2:39)

Chelsea's Hope Research Update Webinar with Ionis Pharmaceuticals - September 27, 2021

(59:58)

Keynote Presentation: Antisense based therapy for rare neurological diseases

(1:9:20)

Coming Together for the Nano-rare Patient

(30:40)